Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 2.91B P/E - EPS this Y -44.00% Ern Qtrly Grth -
Income -20.37M Forward P/E 27.13 EPS next Y 33.60% 50D Avg Chg -8.00%
Sales 1.15B PEG 2.12 EPS past 5Y -4.95% 200D Avg Chg 7.00%
Dividend N/A Price/Book 2.50 EPS next 5Y 12.00% 52W High Chg -43.00%
Recommedations 2.60 Quick Ratio 1.99 Shares Outstanding 45.92M 52W Low Chg 40.00%
Insider Own 1.47% ROA -0.61% Shares Float 45.23M Beta 0.76
Inst Own 101.82% ROE -1.76% Shares Shorted/Prior 2.32M/2.28M Price 64.58
Gross Margin 43.58% Profit Margin -1.78% Avg. Volume 426,117 Target Price 34.50
Oper. Margin -9.00% Earnings Date May 2 Volume 1,388,781 Change 4.67%
About Omnicell, Inc.

Omnicell, Inc., together with its subsidiaries, provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers point of care automation solutions to improve clinician workflows in patient care areas of the healthcare system; XT Series automated dispensing systems for medications and supplies used in nursing units and other clinical areas of the hospital, as well as specialized automated dispensing systems for operating room; and robotic dispensing systems for handling the stocking and retrieval of boxed medications. It also provides central pharmacy automation solutions; IV compounding robots; and inventory management software. In addition, the company provides single-dose automation solutions that fill and label a variety of patient-specific, single-dose medication blister packaging based on incoming prescriptions; fully automated and semi-automated filling equipment for institutional pharmacies to warrant automated packaging of medications; and medication blister card packaging and packaging supplies to enhance medication adherence in non-acute care settings. Further, it offers EnlivenHealth Patient Engagement, a web-based solutions. The company was formerly known as Omnicell Technologies, Inc. and changed its name to Omnicell, Inc. in 2001. Omnicell, Inc. was incorporated in 1992 and is headquartered in Fort Worth, Texas.

OMCL Chatroom

User Image angelomerkel Posted - 15 hours ago

$OMCL Why doesn't this man work for you anymore? Did he do a good job? He is now the new CFO at clov „Mr. Kuipers provided financial leadership and strategic vision, contributing to the company's growth from $485 million to $1.3 billion in revenue.“

User Image UncleStock Posted - 1 day ago

$AGTI $EQX $OMCL $VRNT suggested for Mohanram - value screen: https://zpr.io/Py36cAnPfcbT

User Image DonCorleone77 Posted - 6 days ago

$OMCL Omnicell announces XT Amplify Omnicell announced XT Amplify, a multi-year innovation program that is intended to maximize value for hospitals, health systems, and post-acute care facilities that have invested in Omnicell's XT Automated Dispensing System while also seeking to drive enhanced clinical and operational outcomes at the points of care and within pharmacies. "We recognize that some of our customers are navigating difficult operational and economic environments. We believe Omnicell is nicely positioned to address these current challenges while adapting for the future," said Randall Lipps, chairman, president, chief executive officer, and founder of Omnicell. "We are confident the XT Amplify program will deliver continuous innovation that addresses these evolving and complex needs, while helping customers to maximize outcomes and the value of Omnicell automated dispensing systems currently in use around the globe."

User Image Stock_Titan Posted - 6 days ago

$OMCL Omnicell Announces XT Amplify https://www.stocktitan.net/news/OMCL/omnicell-announces-xt-vjd5shf25ken.html

User Image UncleStock Posted - 1 week ago

$OMCL $AGTI $EQX $EXK suggested for Mohanram - value screen: https://zpr.io/Py36cAnPfcbT

User Image UncleStock Posted - 1 week ago

$AGTI $OMCL $EXK $CSIQ suggested for Mohanram - value screen: https://zpr.io/Py36cAnPfcbT

User Image Stock_Titan Posted - 2 weeks ago

$OMCL Omnicell to Release First Quarter 2024 Financial Results on May 2, 2024 https://www.stocktitan.net/news/OMCL/omnicell-to-release-first-quarter-2024-financial-results-on-may-2-x5er1fv1o4g2.html

User Image UncleStock Posted - 1 month ago

$CDE $OMCL $AGTI $EXK suggested for Mohanram - value screen: https://zpr.io/Py36cAnPfcbT

User Image Stock_Titan Posted - 1 month ago

$OMCL Omnicell to Present at the virtual KeyBanc Annual Life Sciences & MedTech Investor Forum https://www.stocktitan.net/news/OMCL/omnicell-to-present-at-the-virtual-key-banc-annual-life-sciences-amp-0q84p0v1jolp.html

User Image Aggielgr Posted - 1 month ago

$OMCL what caused the P/E ratio down so much? It had always been strong. Just jumping in now.

User Image UncleStock Posted - 02/26/24

$EXK $HBM $TBRG $OMCL suggested for Mohanram - value screen: https://zpr.io/Py36cAnPfcbT

User Image AlexSwiss77 Posted - 2 months ago

$OMCL open position today

User Image DonCorleone77 Posted - 2 months ago

$OMCL Omnicell sees FY24 EPS 90c-$1.40, consensus $1.66 Sees FY24 revenue $1.05BM-$1.12BM, consensus $1.08B. Sees FY24 bookings $750M-$875M. Sees FY24 EBITDA $90M-$120M. The company said, "For the full year 2024, the Company expects bookings to be between $750 million and $875 million. The Company expects full year 2024 total revenues to be between $1.045 billion and $1.120 billion. The Company expects full year 2024 product revenues to be between $605 million and $650 million, and full year 2024 service revenues to be between $440 million and $470 million. The Company expects full year 2024 technical services revenues to be between $220 million and $235 million, and full year 2024 Advanced Services revenues to be between $220 million and $235 million. The Company expects full year 2024 non-GAAP EBITDA to be between $90 million and $120 million. The Company expects full year 2024 non-GAAP earnings per share to be between $0.90 and $1.40 per share."

User Image DonCorleone77 Posted - 2 months ago

$OMCL Omnicell sees Q1 EPS (10c)-0c, consensus 31c Sees Q1 revenue $232M-$242M, consensus $262.37M. Sees Q1 EBITDA loss of $2M to up $4M. The company said, "For the first quarter of 2024, the Company expects total revenues to be between $232 million and $242 million. The Company expects first quarter 2024 product revenues to be between $128 million and $133 million, and first quarter 2024 service revenues to be between $104 million and $109 million. The Company expects first quarter 2024 non-GAAP EBITDA to be between ($2) million and $4 million. The Company expects first quarter 2024 non-GAAP earnings per share to be between a net loss of ($0.10) and breakeven per share."

User Image DonCorleone77 Posted - 2 months ago

$OMCL Omnicell reports Q4 EPS 33c, consensus 15c Reports Q4 revenue $258.85M, consensus $255.56M. Randall Lipps, chairman, president, chief executive officer, and founder of Omnicell, said, "Our team delivered 2023 financial results that were generally in line with what we originally anticipated for the year. We are enthusiastic about our robust innovation pipeline, particularly around our XT fleet of connected devices. We believe the Company is uniquely positioned to capture incremental market share as hospital cost pressures are expected to alleviate and as the macroeconomic environment is anticipated to improve. However, we recognize we have work to do to strengthen our performance and accelerate profitability. To that end, we are undertaking a holistic review of our business to determine how we can best optimize our investments in an effort to deliver strong returns for our stockholders...."

User Image epsguid Posted - 2 months ago

$OMCL reported earnings of $0.33, consensus was ($0.10) via @eWhispers #epsbeat http://eps.sh/d/omcl

User Image Stock_Titan Posted - 2 months ago

$OMCL Omnicell Announces Fiscal Year and Fourth Quarter 2023 Results https://www.stocktitan.net/news/OMCL/omnicell-announces-fiscal-year-and-fourth-quarter-2023-o7bgfld262ix.html

User Image TickerDD_com Posted - 2 months ago

From 1/30/2024, looking back across 22 Month-Ends for OMCL, Percentage Change of Average Monthly Price had More Negatives (64%) while Percentage Change of Average Monthly Volume had All Positives (100%) $OMCL #OMCL #OMCLStock #TickerDD #OMCLPrice https://www.youtube.com/watch?v=XYyfngVYXYc

User Image Teambio Posted - 01/31/24

$OMCL Jumped in yesterday at 32.40 for the long hold.

User Image Nandosaur Posted - 01/30/24

$OMCL ohh boy.

User Image cctranscripts Posted - 3 months ago

BlackRock, Inc. just provided an update on share ownership of Omnicell https://www.conferencecalltranscripts.org/summary/?id=12880018 $OMCL

User Image cctranscripts Posted - 3 months ago

Omnicell insider just declared 0 ownership of the company. https://www.conferencecalltranscripts.org/summary/?id=12869399 $OMCL

User Image cctranscripts Posted - 3 months ago

Omnicell: Senior Vice President, Investor Relations https://www.conferencecalltranscripts.org/summary/?id=12860864 $OMCL

User Image Last10K Posted - 3 months ago

$OMCL just filed with the SEC a Event for Officers, a Regulated Disclosure and a Financial Exhibit https://last10k.com/sec-filings/OMCL/0000926326-24-000002.htm?utm_source=stocktwits&utm_medium=forum&utm_campaign=8K&utm_term=OMCL

User Image risenhoover Posted - 3 months ago

$OMCL / Omnicell files form 8-K - UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): January 5, 2024 OMNICELL, INC. ( https://fintel.io/doc/sec-omnicell-inc-926326-8k-2024-january-11-19733-2986?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=filing

User Image tickeron Posted - 3 months ago

Wow this is a big change! $OMCL price moved above its 50-day Moving Average. View odds of downtrend. https://srnk.us/go/4964662

User Image Aigner_Andreas Posted - 3 months ago

#TrendFollowing #TOP10 WK 02 SELL US $ASYS $ADMP $OMCL $ZTO $EVFM YY GDDY CNS VRM VUZI

User Image UncleStock Posted - 3 months ago

$HBM $FSM $OMCL $TBRG suggested for Mohanram - value screen: https://zpr.io/Py36cAnPfcbT

User Image Valentino76 Posted - 12/29/23

$OMCL this will just keep going up,

User Image cctranscripts Posted - 4 months ago

Omnicell insider just disposed of 222 shares https://www.conferencecalltranscripts.org/summary/?id=12801083 $OMCL

Analyst Ratings
Benchmark Buy Feb 9, 24
Wells Fargo Equal-Weight Feb 9, 24
Wells Fargo Equal-Weight Nov 3, 23
BTIG Neutral Nov 3, 23
Piper Sandler Overweight Nov 3, 23
Keybanc Sector Weight Oct 11, 23
Benchmark Buy Oct 3, 23
Wells Fargo Underweight Sep 26, 23
Keybanc Overweight Aug 4, 23
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
LIPPS RANDALL A CHAIRMAN, PRESIDENT.. CHAIRMAN, PRESIDENT AND CEO Jun 08 Buy 73.76 4,000 295,040 318,768 06/12/23
Seidelmann Scott Peter EVP, CHIEF COMMERCIA.. EVP, CHIEF COMMERCIAL OFFICER Nov 28 Sell 51.46 1,793 92,268 38,996 11/30/22
Kuipers Peter J. EXECUTIVE V P& CFO EXECUTIVE V P& CFO Aug 26 Option 61.58 15,500 954,490 76,826 08/30/22
Kuipers Peter J. EXECUTIVE V P& CFO EXECUTIVE V P& CFO Aug 26 Sell 108.52 15,500 1,682,060 61,326 08/30/22
Kuipers Peter J. EXECUTIVE V P& CFO EXECUTIVE V P& CFO Aug 22 Option 44.25 11,000 486,750 72,326 08/24/22
Kuipers Peter J. EXECUTIVE V P& CFO EXECUTIVE V P& CFO Aug 22 Sell 105.93 11,000 1,165,230 61,326 08/24/22
LIPPS RANDALL A CHAIRMAN, PRESIDENT.. CHAIRMAN, PRESIDENT AND CEO Aug 16 Sell 111.04 13,000 1,443,520 302,049 08/18/22
Seidelmann Scott Peter EVP, CHIEF COMMERCIA.. EVP, CHIEF COMMERCIAL OFFICER Jun 15 Sell 109.86 3,765 413,623 40,789 06/17/22
Seidelmann Scott Peter EVP, Chief Commercia.. EVP, Chief Commercial Officer Mar 14 Sell 133.11 2,525 336,103 48,380 03/16/22
PARRISH MARK W Director Director Mar 10 Option 14.87 2,000 29,740 42,558 03/11/22
PARRISH MARK W Director Director Feb 18 Option 14.87 3,000 44,610 40,558 02/22/22
JOHNSTON DAN S EVP & Chief Legal &.. EVP & Chief Legal & Admin Dec 15 Sell 177.06 1,063 188,215 25,831 12/16/21
Seidelmann Scott Peter EVP, Chief Commercia.. EVP, Chief Commercial Officer Dec 15 Sell 177.24 3,628 643,027 33,632 12/16/21
Kuipers Peter J. Executive V P& CFO Executive V P& CFO Dec 08 Option 0 5,640 59,592 12/08/21
Kuipers Peter J. Executive V P& CFO Executive V P& CFO Dec 08 Sell 181.15 8,517 1,542,855 51,075 12/08/21
SPEARS JOSEPH BRIAN Chief Accounting Off.. Chief Accounting Officer & VP Dec 07 Sell 180.98 8,155 1,475,892 9,399 12/08/21
JOHNSTON DAN S EVP & Chief Legal &.. EVP & Chief Legal & Admin Oct 26 Option 0 10,451 39,427 10/27/21
JOHNSTON DAN S EVP & Chief Legal &.. EVP & Chief Legal & Admin Oct 26 Sell 170 10,451 1,776,670 28,976 10/27/21
Kuipers Peter J. Executive V P& CFO Executive V P& CFO May 18 Sell 135.59 2,395 324,738 69,454 05/18/21
LIPPS RANDALL A Chairman, President.. Chairman, President and CEO Dec 09 Option 0 25,000 177,116 12/09/20
LIPPS RANDALL A Chairman, President.. Chairman, President and CEO Dec 09 Sell 122.61 25,000 3,065,250 152,116 12/09/20
LIPPS RANDALL A Chairman, President.. Chairman, President and CEO Dec 08 Option 0 17,500 152,767 12/08/20
LIPPS RANDALL A Chairman, President.. Chairman, President and CEO Dec 08 Sell 110.8 17,500 1,939,000 152,116 12/08/20
LIPPS RANDALL A Chairman, President.. Chairman, President and CEO Nov 23 Option 0 15,000 164,716 11/23/20
LIPPS RANDALL A Chairman, President.. Chairman, President and CEO Nov 23 Sell 105.21 15,000 1,578,150 152,116 11/23/20
LIPPS RANDALL A Chairman, President.. Chairman, President and CEO Nov 04 Sell 89.83 11,435 1,027,206 229,113 11/04/20
LIPPS RANDALL A Chairman, President.. Chairman, President and CEO Sep 16 Sell 75.59 15,143 1,144,659 240,548 09/16/20